No results for ‘’
Parnax Lab Ltd
₹142.95
(5.95%)
Sun, 31 May 2026, 08:58 pm
Health Technology
Pharmaceuticals: Major
24.5KParnax Lab Ratios
| Particulars | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 8.69 | 0 | 0 | 13.59 | 6.69 | 15.48 | 10.67 |
| Price to book ratio | 0.80 | 0.31 | 0.51 | 2.68 | 0.96 | 2.08 | 1.48 |
| Price to sales ratio | 0.26 | 0.11 | 0.18 | 0.69 | 0.34 | 0.79 | 0.65 |
| Price to cash flow ratio | 5.18 | 2.44 | 12.66 | 32.90 | 3.59 | 13.59 | 4.54 |
| Enterprise value | 700.82M | 603.14M | 742.97M | 1.75B | 1.1B | 2.28B | 1.9B |
| Enterprise value to EBITDA ratio | 6.52 | 8.88 | 7.33 | 7.47 | 4.73 | 9.63 | 6.98 |
| Debt to equity ratio | 1.17 | 1.56 | 1.81 | 1.43 | 0.88 | 1.13 | 0.84 |
| Return on equity % | 0 | -8.51 | -1.11 | 20.42 | 15.62 | 14.37 | 14.89 |
Parnax Lab Ltd Ratios
The Parnax Lab Ltd Ratios page provides a complete fundamental analysis of Parnax Lab Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Parnax Lab Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Parnax Lab Ltd (NSE: , BSE: 506128) is currently trading at ₹142.95, with a market capitalization of ₹1.64B. As a major player in the Health technology sector and Pharmaceuticals: major industry, Parnax Lab Ltd remains a key stock for fundamental analysis using Parnax Lab Ltd Ratios.
Parnax Lab Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Parnax Lab Ltd P/E ratio currently stands at 10.67, making it one of the most tracked metrics in Parnax Lab Ltd Ratios.
Historically, the Parnax Lab Ltd P/E ratio has shown strong fluctuations:
- 2024: 10.67
- 2023: 15.48
- 2022: 6.69
- 2021: 13.59
- 2020: 0
The decline in Parnax Lab Ltd P/E ratio suggests improving earnings relative to stock price.
Price to Book Ratio (P/B)
The Parnax Lab Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.48.
Historical P/B trend:
- 2024: 1.48
- 2023: 2.08
- 2022: 0.96
- 2021: 2.68
Parnax Lab Ltd shows reasonable valuation compared to its asset base.
Price to Sales Ratio (P/S)
The Parnax Lab Ltd P/S ratio currently stands at 0.65, an important part of Parnax Lab Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 0.65
- 2023: 0.79
- 2022: 0.34
- 2021: 0.69
A stable or declining Parnax Lab Ltd P/S ratio indicates cautious market sentiment.
Parnax Lab Ltd Price to Cash Flow Ratio (P/CF)
The Parnax Lab Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 4.54.
Historical Parnax Lab Ltd Price to Cash Flow Ratio:
- 2024: 4.54
- 2023: 13.59
- 2022: 3.59
- 2021: 32.90
- 2020: 12.66
The declining Parnax Lab Ltd Price to Cash Flow Ratio suggests improving cash flow strength.
Parnax Lab Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Parnax Lab Ltd EV currently stands at ₹1.9B, representing the total company valuation including debt.
Historical EV trend:
- 2024: 1.9B
- 2023: 2.28B
- 2022: 1.1B
- 2021: 1.75B
Parnax Lab Ltd enterprise value consolidation suggests stable valuation.
EV/EBITDA Ratio
The Parnax Lab Ltd EV/EBITDA ratio is currently 6.98, a key metric in Parnax Lab Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2024: 6.98
- 2023: 9.63
- 2022: 4.73
- 2021: 7.47
Stable Parnax Lab Ltd EV/EBITDA indicates balanced valuation.
Parnax Lab Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Parnax Lab Ltd D/E ratio is currently 0.84, reflecting leverage and financial stability.
Historical D/E:
- 2024: 0.84
- 2023: 1.13
- 2022: 0.88
- 2021: 1.43
Parnax Lab Ltd maintains moderate leverage with manageable risk.
Return on Equity (ROE %)
The Parnax Lab Ltd ROE currently stands at 14.89%, showing profitability and capital efficiency.
Historical ROE:
- 2024: 14.89
- 2023: 14.37
- 2022: 15.62
- 2021: 20.42
Parnax Lab Ltd maintains stable profitability levels.
Parnax Lab Ltd Ratios Analysis Summary
The Parnax Lab Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Parnax Lab Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Parnax Lab Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.